A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...

MIAMI, FLORIDA (OCT. 20, 2025) – A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for patients with advanced neuroendocrine tumors ...

Tricking cancer cells into self-destructing could reduce risk of recurrence and death in colon cancer by 50%. Results also ...

Transcutaneous Auricular Neurostimulation Research Platform from Spark Biomedical, Inc.

Circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — may help risk-stratify patients with ...

Federal funding has long played a crucial role in supporting research at Duke, a point underscored in a 1989 letter to the ...